Richard Manning provides insights based on economic theory and data analysis to help clients solve complex problems arising in a variety of business settings with an emphasis on biopharmaceuticals in both prescription and OTC settings, medical devices, life sciences, and animal health. Dr. Manning has testified in U.S. District Court, U.S. Bankruptcy Court, the Delaware Court of Chancery, the United States Patent Trial and Appeals Board, and the International Chamber of Commerce. He has served as a consulting expert and prepared reports and commentary on a wide range of issues in the biopharmaceutical (both innovative and follow-on sectors) and healthcare industries. His career includes 14 years as an executive in multinational pharmaceutical companies, where he led economic analysis and strategy development to shape practices on emerging business concerns.